Friday, February 25, 2022
8:45 AM-10:45 AM ET
Tracy I. George, MD
(Virtual Professor)
Professor of Pathology
University of Utah School of Medicine
President and Chief Medical Officer
ARUP Laboratories
Salt Lake City, Utah
Matthew J. Hamilton MD
Assistant Professor of Medicine
Harvard Medical School
Lead Gastroenterologist
Brigham and Women’s Hospital Mastocytosis Center
Boston, Massachusetts
Anne Maitland, MD, PhD
Assistant Clinical Professor, Icahn School of Medicine
Department of Medicine Allergy & Clinical Immunology
New York, New York
Immunologist, Chiari EDS Mast Cell Activation Disorders Center
Mount Sinai South Nassau
Oceanside, New York
Lawrence B. Schwartz, MD, PhD
Charles & Evelyn Thomas Professor of Medicine
Chair, Division of Rheumatology Allergy & Immunology
Virginia Commonwealth University
Richmond, Virginia
Please join us for a live stream of this Non-CME Educational Program during the American Academy of Allergy, Asthma & Immunology (AAAAI) 2022 Annual Meeting.
This program is not sponsored or programmed by the AAAAI.
Target Audience
Allergists/clinical immunologists, dermatologists, gastroenterologists, hematologists/oncologists, and other specialist clinicians who treat patients with nonadvanced systemic mastocytosis.
Program Description
This Interactive Exchange™ educational program focuses on the identification and management of patients with nonadvanced systemic mastocytosis (SM). The program will open with a brief video segment featuring a 3D animation detailing the pathophysiological drivers of SM and their implications for the development of targeted therapies. Dynamic discussions among a multidisciplinary panel of experts will address challenges in the diagnosis and classification of nonadvanced SM, highlight recent clinical trial data on emerging targeted therapies, and emphasize real-world strategies for the comprehensive management of nonadvanced SM. The program will conclude with an engaging case study discussion highlighting the various clinical presentations of nonadvanced SM along with expert advice for practical and effective disease management. Please join us for this informative and engaging session.
Learning Objectives
Upon completion of this activity, the participant should be better able to:
- Describe clinically relevant pathophysiology in the development of systemic mastocytosis, including the effects of driver mutations on mast cell hyperactivation
- Identify patients with nonadvanced systemic mastocytosis based on symptomatology and appropriate ancillary testing
- Discuss the clinical profiles and trial evidence for current and emerging targeted treatment options in nonadvanced systemic mastocytosis
- Tailor therapeutic regimens for patients with nonadvanced systemic mastocytosis based on symptoms, risk stratification, treatment responses, and appropriate consultations with other specialist clinicians
Agenda
12:00 PM ET Introductions
12:10 PM ET What Is the Latest on Systemic Mastocytosis Pathophysiology?
12:20 PM ET Meet the Professors Discussion on Systemic Mastocytosis
01:20 PM ET Choose-a-Case: Prerecorded Patient Examples of Systemic Mastocytosis
01:35 PM ET Question & Answer Session
This activity is provided by Integritas Communications.
This activity is supported by an independent educational grant from Blueprint Medicines Corporation.
This activity is endorsed by The Mast Cell Disease Society, Inc.
There is no registration fee for attending this program.
This live activity will not offer continuing medical education (CME) credit.
Register Now
24
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:30 PM-1:30 PM CT |
Venue: | Cahaba Medical Care - In-Person Event |
Location: | Birmingham, AL |
Faculty: | Ellen F. Eaton, MD, MSPH, FIDSA |
01
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mostellar Medical - In-Person Event |
Location: | Irvington, AL |
Faculty: | William S. Bradford, MD |
08
2024
BRIDGE HCV
Building Bridges To Reach People Who Inject Drugs With The Goal To Eliminate HCV
Time: | 12:00 PM-1:00 PM CT |
Venue: | Mostellar Medical - In-Person Event |
Location: | Irvington, AL |
Faculty: | William S. Bradford, MD |
15
2024
Tackling Chronic Inflammatory Airway Diseases
A Unified Picture of Disease Processes and Targeted Management
Time: | 6:00 PM-8:00 PM CT |
Venue: | Hyatt Regency Chicago, Grand GH |
Location: | Chicago, IL |
Faculty: | Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI |
15
2024
Tackling Chronic Inflammatory Airway Diseases
A Unified Picture of Disease Processes and Targeted Management
Time: | 6:30 PM-8:00 PM CT |
Venue: | Live Stream |
Location: | Live Stream |
Faculty: | Joseph K. Han, MD, FARS, FAAAAI, FAAOA; Amber U. Luong, MD, PhD, FACS; Anju T. Peters, MD, MSCI |
20
2024
An Expert Panel on Severe Asthma
From the Epithelium to Better Patient Outcomes
Time: | 6:30 PM-8:00 PM PT |
Venue: | Hilton Bayfront San Diego - Indigo Ballroom CGDH |
Location: | Indigo Ballroom CGDH |
Faculty: | Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc; Geoffrey Chupp, MD |
20
2024
An Expert Panel on Severe Asthma
From the Epithelium to Better Patient Outcomes
Time: | 6:30 PM-8:00 PM PT |
Venue: | Live Stream |
Location: | Live Stream |
Faculty: | Geoffrey Chupp, MD; Njira Lucia Lugogo, MD, MS; Michael E. Wechsler, MD, MMSc |